tabirafusp tedromer (KSI-501) / Kodiak Sciences 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tabirafusp tedromer (KSI-501) / Kodiak Sciences
DAYBREAK, NCT06556368: A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) -

Recruiting
3
675
US
Tarcocimab tedromer, KSI-301, Tabirafusp tedromer, KSI-501, Aflibercept, Eylea
Kodiak Sciences Inc
Wet Age-related Macular Degeneration
01/26
01/26

Download Options